HomeAI · summaries
Storia in 2 fonti
AI’s next pharma challenge: tackling costly and risky clinical trials
Drug companies are betting AI can fix the slow, expensive process of testing new drugs in humans.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
venturebeat.com
Agentic AI in production: Merck, Mastercard on what works
Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes. Both say infrastructure came first.
- ·
swissinfo.ch
AI’s next pharma challenge: tackling costly and risky clinical trials
Drug companies are betting AI can fix the slow, expensive process of testing new drugs in humans.